Lipitor generic name
Pro Research Analysisby 
Searched over 200M research papers
Consensus Meter
Lipitor Generic Name: Atorvastatin
Introduction to Lipitor and Its Generic Equivalent
Lipitor, a widely prescribed statin, is used to lower cholesterol and reduce the risk of heart disease. The generic name for Lipitor is atorvastatin. This generic version became available after Lipitor's patent expired in June 2011, with the first generic atorvastatin entering the market on November 30, 2011.
Economic Impact of Generic Atorvastatin
The introduction of generic atorvastatin has had significant economic implications. Before the availability of the generic version, Lipitor was the top-selling prescription drug in the United States in 2010. The transition to generic atorvastatin was expected to reduce healthcare costs substantially. Studies have shown that the availability of generic atorvastatin could lead to substantial cost savings for patients and healthcare plans without compromising clinical effectiveness .
Clinical Effectiveness and Safety of Generic Atorvastatin
Concerns often arise regarding the clinical effectiveness and safety of generic medications compared to their brand-name counterparts. However, research comparing Lipitor and generic atorvastatin has shown no significant differences in clinical outcomes. A population-based cohort study in Ontario, Canada, involving patients aged 65 and older who were discharged after an acute coronary syndrome (ACS) hospitalization, found no significant difference in the rates of death or recurrent ACS hospitalization between those prescribed Lipitor and those prescribed generic atorvastatin at one year . Additionally, no significant differences were observed in secondary outcomes such as hospitalization for heart failure, stroke, new-onset diabetes, rhabdomyolysis, and renal failure .
Cost-Effectiveness and Market Competition
The introduction of generic atorvastatin has also influenced market competition and pricing strategies. Pfizer, the manufacturer of Lipitor, implemented programs to ensure that patients could continue to access Lipitor at a cost comparable to or lower than the generic version during the initial 180-day period following the loss of market exclusivity. This strategy aimed to enhance competition and maintain patient access to the branded medication while promoting cost savings.
Conclusion
The generic name for Lipitor is atorvastatin. The availability of generic atorvastatin has led to significant cost savings in healthcare without compromising clinical effectiveness or safety. Studies have consistently shown that generic atorvastatin is as effective and safe as Lipitor for patients, particularly those with acute coronary syndrome. The introduction of generic atorvastatin has also fostered market competition, further driving down costs and benefiting both patients and healthcare systems.
Sources and full results
Most relevant research papers on this topic